B
Boston Scientific Corporation BSX
$106.13 -$0.265-0.25% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 22.84% 20.93% 22.44% 19.34% 14.48%
Total Other Revenue -- -- -- -- --
Total Revenue 22.84% 20.93% 22.44% 19.34% 14.48%
Cost of Revenue 29.09% 20.34% 27.37% 18.44% 19.53%
Gross Profit 20.03% 21.20% 20.22% 19.75% 12.34%
SG&A Expenses 18.67% 17.08% 16.90% 25.76% 6.79%
Depreciation & Amortization 5.63% 2.34% 8.17% -1.44% 1.43%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 24.00% 17.80% 21.33% 19.64% 10.96%
Operating Income 18.02% 35.21% 28.04% 17.90% 31.85%
Income Before Tax 124.05% 32.18% 15.84% 9.67% -1.41%
Income Tax Expenses 48.98% 15.65% 2,200.00% 90.48% -37.18%
Earnings from Continuing Operations 146.89% 36.03% 11.51% -7.13% 19.26%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings 0.00% 100.00% 300.00% -- --
Net Income 145.99% 36.16% 12.08% -7.13% 20.00%
EBIT 18.02% 35.21% 28.04% 17.90% 31.85%
EBITDA 15.23% 26.58% 22.37% 12.65% 22.79%
EPS Basic 144.44% 35.36% 11.23% -7.63% 22.05%
Normalized Basic EPS 75.67% 34.03% 31.86% 22.72% 39.73%
EPS Diluted 140.91% 36.36% 11.97% -6.32% 22.22%
Normalized Diluted EPS 75.65% 33.76% 31.51% 22.39% 39.41%
Average Basic Shares Outstanding 0.63% 0.60% 0.61% 0.56% 1.69%
Average Diluted Shares Outstanding 0.63% 0.77% 0.90% 0.84% 1.92%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --